These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
724 related items for PubMed ID: 36192801
1. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study. Al Sulaiman K, Korayem GB, Altebainawi AF, Al Harbi S, Alissa A, Alharthi A, Kensara R, Alfahed A, Vishwakarma R, Al Haji H, Almohaimid N, Al Zumai O, Alrubayan F, Asiri A, Alkahtani N, Alolayan A, Alsohimi S, Melibari N, Almagthali A, Aljahdali S, Alenazi AA, Alsaeedi AS, Al Ghamdi G, Al Faris O, Alqahtani J, Al Qahtani J, Alshammari KA, Alshammari KI, Aljuhani O. Crit Care; 2022 Oct 03; 26(1):304. PubMed ID: 36192801 [Abstract] [Full Text] [Related]
7. Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile? Lotz C, Muellenbach RM, Meybohm P, Mutlak H, Lepper PM, Rolfes CB, Peivandi A, Stumpner J, Kredel M, Kranke P, Torje I, Reyher C. Acta Anaesthesiol Scand; 2021 May 03; 65(5):629-632. PubMed ID: 33296498 [Abstract] [Full Text] [Related]
8. Inhaled Nitric Oxide in Acute Severe Pulmonary Hypertension and Severe Acute Respiratory Distress Syndrome Secondary to COVID-19 Pneumonia: A Case Report. Vives M, Gascó I, Pla G, Maciel JL, Ricart Hernandez A, Regí Roman K, Parramon F. Am J Case Rep; 2022 Oct 25; 23():e937147. PubMed ID: 36281210 [Abstract] [Full Text] [Related]
9. Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19. Poonam PBH, Koscik R, Nguyen T, Rikhi S, Lin HM. PLoS One; 2022 Oct 25; 17(6):e0270646. PubMed ID: 35759496 [Abstract] [Full Text] [Related]
12. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19. Matthews L, Baker L, Ferrari M, Sanchez W, Pappachan J, Grocott MP, Dushianthan A, REACT COVID-19 investigators. J Intensive Care Med; 2022 Aug 25; 37(8):1101-1111. PubMed ID: 35369798 [Abstract] [Full Text] [Related]
14. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities. Alser O, Mokhtari A, Naar L, Langeveld K, Breen KA, El Moheb M, Kapoen C, Gaitanidis A, Christensen MA, Maurer LR, Mashbari H, Bankhead-Kendall B, Parks J, Fawley J, Saillant N, Mendoza A, Paranjape C, Fagenholz P, King D, Lee J, Farhat MR, Velmahos GC, Kaafarani HMA. J Trauma Acute Care Surg; 2021 May 01; 90(5):880-890. PubMed ID: 33891572 [Abstract] [Full Text] [Related]
15. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study. Al Sulaiman K, Aljuhani O, Al Aamer K, Al Shaya O, Al Shaya A, Alsaeedi AS, Alhubaishi A, Altebainawi AF, Al Harthi A, Albelwi S, Almutairi R, Alsubaie N, Alsallum A, Korayem GB, Alfahed A, Kensara R, Altebainawi EF, Alenezi RS, Alsulaiman T, Al Enazi H, Vishwakarma R, Al Dabbagh T, Bakhsh U, Al Ghamdi G. J Intensive Care Med; 2022 Feb 01; 37(2):248-257. PubMed ID: 34757869 [Abstract] [Full Text] [Related]